Yeh we're all good cash wise through to Aus and US results and FDA submission I reckon!
Can't see a reason for a CR if all results come back >70% as required. By the time they run out of cash we'll probably have been bought out, or certainly have revenue streams coming in!
Ann: ResApp Receives R&D Tax Incentive Cash Rebate for FY17, page-5
Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #
